These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy. Feeney GF; Connor JP; Young RM; Tucker J; McPherson A Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406 [TBL] [Abstract][Full Text] [Related]
26. [Depression in alcohol addicted patients]. Ponizovskiy PA; Gofman AG Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(7):146-150. PubMed ID: 26356528 [TBL] [Abstract][Full Text] [Related]
27. Drug treatment for alcoholism today. Harv Ment Health Lett; 2005 Jul; 22(1):3-5. PubMed ID: 16193562 [No Abstract] [Full Text] [Related]
28. Opioid antagonists for the treatment of alcohol dependence. Yancey JR; Lumbad J Am Fam Physician; 2011 Nov; 84(9):990-2. PubMed ID: 22046937 [No Abstract] [Full Text] [Related]
29. [Recent results in relaps prevention of alcoholism with Disulfiram]. Mutschler J; Diehl A; Vollmert C; Herre H; Mann K; Kiefer F Neuropsychiatr; 2008; 22(4):243-51. PubMed ID: 19080995 [TBL] [Abstract][Full Text] [Related]
30. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland. Buri C; Moggi F; Giovanoli A; Strik W Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820 [TBL] [Abstract][Full Text] [Related]
31. Extended-release intramuscular naltrexone: a viewpoint by Henry R Kranzler. Kranzler HR Drugs; 2006; 66(13):1753-4. PubMed ID: 16978038 [No Abstract] [Full Text] [Related]
32. Addiction medicine for the primary care physician. Yarborough WH J Okla State Med Assoc; 2001 Nov; 94(11):499-506. PubMed ID: 11729596 [TBL] [Abstract][Full Text] [Related]
33. [Pharmacological treatment of alcohol dependence. Acamprosate and naltrexone offer new approach]. Berglund M; Balldin J; Bendtsen P; Borg S; Franck J; Gustafsson L; Halldin J; Månsson M; Nilsson LH; Stolt G; Willander A Lakartidningen; 1997 Jul; 94(30-31):2645-8. PubMed ID: 9273426 [No Abstract] [Full Text] [Related]
34. The role of Antabuse (disulfiram) in the treatment of alcohol use problems. Behav Healthc Tomorrow; 2003; Suppl():2-15. PubMed ID: 12825302 [No Abstract] [Full Text] [Related]
35. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study. Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A; Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666 [TBL] [Abstract][Full Text] [Related]
36. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782 [TBL] [Abstract][Full Text] [Related]
37. Expectancy in double-blind placebo-controlled trials: an example from alcohol dependence. Colagiuri B; Morley K; Boakes R; Haber P Psychother Psychosom; 2009; 78(3):167-71. PubMed ID: 19270472 [TBL] [Abstract][Full Text] [Related]
38. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence. Baser O; Chalk M; Rawson R; Gastfriend DR Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948 [TBL] [Abstract][Full Text] [Related]
39. From the neurobiologic basis of alcohol dependency to pharmacologic treatment strategies: bridging the knowledge gap. Shea CW South Med J; 2008 Feb; 101(2):179-85. PubMed ID: 18364621 [TBL] [Abstract][Full Text] [Related]
40. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. De Sousa A; De Sousa A Alcohol Alcohol; 2004; 39(6):528-31. PubMed ID: 15525790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]